Priyam Vora, AJMC

home / authors / priyam-vora-ajmc

Articles

TBO-Filgrastim Offers Significant Cost Savings Over Filgrastim in Myeloma Treatment

TBO-Filgrastim Offers Significant Cost Savings Over Filgrastim in Myeloma Treatment

Priyam Vora, AJMC
February 11th 2016

Bone marrow stimulant helps the body make white blood cells after receiving cancer medications.

Read More

Nearly Half of American Adults Clueless About Their Annual Health Check-Up

Nearly Half of American Adults Clueless About Their Annual Health Check-Up

Priyam Vora, AJMC
December 23rd 2015

American adults largely ignorant that insurance covers annual check-ups and there is no cost out-of-pocket associated with it.

Read More

Clinical Home Visits Reduce Hospital Admissions for Medicare Beneficiaries

Clinical Home Visits Reduce Hospital Admissions for Medicare Beneficiaries

Priyam Vora, AJMC
December 23rd 2015

Under this program, a physician or nurse practitioner visits the Medicare recipient

Read More

Latest Updated Articles

AI patient pharmacist provider interactions ASHP summer
Published: June 11th 2024 | Updated: July 27th 2024
Balancing Trust and Technology: The Role of AI in Patient-Pharmacist Interactions
AI pharmacy futures AI disparities skin
Published: June 11th 2024 | Updated: July 27th 2024
Addressing Disparities in AI-Driven Diagnostics: Ethical and Practical Implications
Vice President Kamala Harris -- Image credit: Erin Schaff/Pool/AFP | GETTY | People.com
Published: July 23rd 2024 | Updated: July 27th 2024
VP Kamala Harris’s Policies and Stances on Health Care, Reproductive Rights Take Center Stage
3d illustration of Abstract medical background with Diseased liver - Image credit: Rasi | stock.adobe.com
Published: October 18th 2023 | Updated: July 27th 2024
Pharmacists Can Optimize Treatment for Patients with NASH, Decreasing Economic Burden
Small vial of influenza vaccine.
Published: July 23rd 2024 | Updated: July 27th 2024
Trivalent Influenza Vaccines Are Readied for Fall
Eye Care Pharmacy | Image Credit: I Viewfinder - stock.adobe.com
Published: July 15th 2024 | Updated: July 27th 2024
Biosimilar Ranibizumab Could be More Cost-Effective Than Aflibercept for nAMD